Strategic Wealth Partners’s Definium Therapeutics DFTX Stock Holding History
Bought
Maintained
Sold
Other funds holding DFTX
Strategic Wealth Partners's DFTX Position: Q3 2026 in Review
Strategic Wealth Partners reduced its Definium Therapeutics (DFTX) stake by 39% in Q3 2026, selling an estimated $7K and leaving 263 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #733.
Strategic Wealth Partners first reported a position in DFTX in Q4 2025 and has held it in 4 quarters since. The position peaked at $20.2K in Q2 2026. 349 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.
- Strategic Wealth Partners held 263 shares of Definium Therapeutics worth $10K as of Q3 2026.
- Strategic Wealth Partners sold 166 Definium Therapeutics shares in Q3 2026, an estimated $7K.
- Definium Therapeutics made up ﹤0.01% of Strategic Wealth Partners's portfolio in Q3 2026, its #733 holding.
- Strategic Wealth Partners first reported a position in Definium Therapeutics in Q4 2025 and has held it in 4 quarters since.
- Strategic Wealth Partners's Definium Therapeutics position peaked at $20.2K in Q2 2026.
- 349 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.
Based on Strategic Wealth Partners's 13F filing for Q3 2026, filed 13 Nov 2026.